NasdaqGS - Delayed Quote USD

Apyx Medical Corporation (APYX)

Compare
1.2100 +0.1100 (+10.00%)
At close: October 25 at 4:00 PM EDT
1.2100 0.00 (0.00%)
After hours: October 25 at 7:52 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Charles D. Goodwin II President, CEO & Director 813.13k -- 1966
Mr. Matthew C. Hill CPA CFO, Treasurer & Secretary 445.95k -- 1969
Mr. Moshe Citronowicz Senior Vice President 405.47k -- 1953
Mr. Todd Hornsby Executive Vice President 561.77k -- 1977
Mr. Stavros George Vizirgianakis B.Com. Executive Chairman -- -- 1971

Apyx Medical Corporation

5115 Ulmerton Road
Clearwater, FL 33760-4004
United States
727 384 2323 https://apyxmedical.com
Sector:?
Healthcare
Industry:?
Medical Devices
Full Time Employees:?
252

Description

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Corporate Governance

Apyx Medical Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 8, 2024 at 1:30 PM UTC

Apyx Medical Corporation Earnings Date

Recent Events

August 12, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 8, 2024 at 9:00 PM UTC

Q2 2024 Earnings Call

August 8, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

June 25, 2024 at 12:00 AM UTC

DEF 14A: Proxy Statements

May 31, 2024 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

May 9, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 21, 2024 at 12:00 AM UTC

10-K: Periodic Financial Reports

February 21, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 22, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 8, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers